OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration

Background. Currently, the role of oncostatin M (OSM) in clear cell renal cell carcinoma (ccRCC) has not been investigated. This study will explore the impact of OSM on ccRCC expression, prognosis, and cell function. Materials and Methods. In this study, we used The Cancer Genome Atlas (TCGA) databa...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuzhang Wei, Yin Chen, Xiaokai Shi, Li Zuo, Lifeng Zhang
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2023/6665452
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546574876540928
author Shuzhang Wei
Yin Chen
Xiaokai Shi
Li Zuo
Lifeng Zhang
author_facet Shuzhang Wei
Yin Chen
Xiaokai Shi
Li Zuo
Lifeng Zhang
author_sort Shuzhang Wei
collection DOAJ
description Background. Currently, the role of oncostatin M (OSM) in clear cell renal cell carcinoma (ccRCC) has not been investigated. This study will explore the impact of OSM on ccRCC expression, prognosis, and cell function. Materials and Methods. In this study, we used The Cancer Genome Atlas (TCGA) database to evaluate OSM expression characteristics, pathogenic factor distribution, and prognostic aspects in ccRCC. We also combined this analysis with qRT-PCR to verify OSM mRNA expression levels at the tissue level. Then, the effects of OSM on the proliferation, invasion, and migration abilities of ccRCC cells were explored through CCK8, Transwell, Western blotting, and immunofluorescence experiments. Finally, the oncogenic mechanisms associated with OSM in ccRCC were explored through signaling pathway enrichment and single-cell analysis. Results. The results demonstrated that OSM was significantly more expressed in ccRCC than in normal tissues. According to the survival analysis, OSM in ccRCC was considerably worse in the group with high expression than in the group with low expression. Also, the univariate and multivariate Cox analyses of clinical characteristics show that OSM in ccRCC may be able to predict a poor prognosis on its own as a biomarker. In vitro cellular experiments demonstrated that high OSM expression had no discernible impact on ccRCC cell proliferation compared to the control group, but it did promote tumor cell invasion and migration. Signaling pathways and single-cell analysis revealed that OSM might promote ccRCC invasion and migration through M2 macrophages. Conclusion. In conclusion, OSM may serve as an independent poor prognostic biomarker in ccRCC and promote tumor cell invasion and migration. This discovery is expected to provide a new therapeutic target for patients with recurrent and metastatic ccRCC.
format Article
id doaj-art-03a5b6f4e44b41b09140fee031b8e05f
institution Kabale University
issn 2314-4378
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-03a5b6f4e44b41b09140fee031b8e05f2025-02-03T06:47:46ZengWileyInternational Journal of Genomics2314-43782023-01-01202310.1155/2023/6665452OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and MigrationShuzhang Wei0Yin Chen1Xiaokai Shi2Li Zuo3Lifeng Zhang4Department of UrologyDepartment of UrologyDepartment of UrologyDepartment of UrologyDepartment of UrologyBackground. Currently, the role of oncostatin M (OSM) in clear cell renal cell carcinoma (ccRCC) has not been investigated. This study will explore the impact of OSM on ccRCC expression, prognosis, and cell function. Materials and Methods. In this study, we used The Cancer Genome Atlas (TCGA) database to evaluate OSM expression characteristics, pathogenic factor distribution, and prognostic aspects in ccRCC. We also combined this analysis with qRT-PCR to verify OSM mRNA expression levels at the tissue level. Then, the effects of OSM on the proliferation, invasion, and migration abilities of ccRCC cells were explored through CCK8, Transwell, Western blotting, and immunofluorescence experiments. Finally, the oncogenic mechanisms associated with OSM in ccRCC were explored through signaling pathway enrichment and single-cell analysis. Results. The results demonstrated that OSM was significantly more expressed in ccRCC than in normal tissues. According to the survival analysis, OSM in ccRCC was considerably worse in the group with high expression than in the group with low expression. Also, the univariate and multivariate Cox analyses of clinical characteristics show that OSM in ccRCC may be able to predict a poor prognosis on its own as a biomarker. In vitro cellular experiments demonstrated that high OSM expression had no discernible impact on ccRCC cell proliferation compared to the control group, but it did promote tumor cell invasion and migration. Signaling pathways and single-cell analysis revealed that OSM might promote ccRCC invasion and migration through M2 macrophages. Conclusion. In conclusion, OSM may serve as an independent poor prognostic biomarker in ccRCC and promote tumor cell invasion and migration. This discovery is expected to provide a new therapeutic target for patients with recurrent and metastatic ccRCC.http://dx.doi.org/10.1155/2023/6665452
spellingShingle Shuzhang Wei
Yin Chen
Xiaokai Shi
Li Zuo
Lifeng Zhang
OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
International Journal of Genomics
title OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
title_full OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
title_fullStr OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
title_full_unstemmed OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
title_short OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
title_sort osm may serve as a biomarker of poor prognosis in clear cell renal cell carcinoma and promote tumor cell invasion and migration
url http://dx.doi.org/10.1155/2023/6665452
work_keys_str_mv AT shuzhangwei osmmayserveasabiomarkerofpoorprognosisinclearcellrenalcellcarcinomaandpromotetumorcellinvasionandmigration
AT yinchen osmmayserveasabiomarkerofpoorprognosisinclearcellrenalcellcarcinomaandpromotetumorcellinvasionandmigration
AT xiaokaishi osmmayserveasabiomarkerofpoorprognosisinclearcellrenalcellcarcinomaandpromotetumorcellinvasionandmigration
AT lizuo osmmayserveasabiomarkerofpoorprognosisinclearcellrenalcellcarcinomaandpromotetumorcellinvasionandmigration
AT lifengzhang osmmayserveasabiomarkerofpoorprognosisinclearcellrenalcellcarcinomaandpromotetumorcellinvasionandmigration